The role of neutrophils in the pathogenesis of systemic lupus erythematosus

Current Opinion in Rheumatology

Volumn 27, Issue 5, 2015, Pages 448-453

  Smith, Carolyne K ^a   Kaplan, Mariana J ^a  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

Bone marrow; Low density granulocytes; Neutrophil extracellular traps; Neutrophils; Systemic lupus erythematosus

Indexed keywords

APRIL PROTEIN; B CELL ACTIVATING FACTOR; BIOLOGICAL MARKER; INTERFERON; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; BLOOD VESSEL INJURY; BONE MARROW; EPIGENETICS; EXTRACELLULAR TRAP; HUMAN; NEUTROPHIL; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; GENETICS; IMMUNOLOGY; INNATE IMMUNITY;

ADAPTIVE IMMUNITY; EXTRACELLULAR TRAPS; HUMANS; IMMUNITY, INNATE; LUPUS ERYTHEMATOSUS, SYSTEMIC; NEUTROPHILS;

EID: 84942570773     PISSN: 10408711     EISSN: 15316963     Source Type: Journal    
DOI: 10.1097/BOR.0000000000000197     Document Type: Review

References (70)

1. Bardoel BW, Kenny EF, Soll berger G, Zychlinsky A. The balancing act of neutrophils. Cell Host Microbe 2014; 15:526-536.
2. Pillay J, den Braber I, Vrisekoop N, et al. In vivo labeling with 2H2O reveals a human neutrophil lifespan of 5.4 days. Blood 2010; 116:625-627.
3. Kolaczkowska E, Kubes P. Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol 2013; 13:159-175.
4. Manz MG, Boettcher S. Emergency granulopoiesis. Nat Rev Immunol 2014; 14:302-314.
5. Summers C, Rankin SM, Condliffe AM, et al. Neutrophil kinetics in health and disease. Trends Immunol 2010; 31:318-324.
6. Mantovani A,Cassatella MA,Costantini C,Jaillon S. Neutrophils in the activation and regulation of innate and adaptive immunity Nat Rev Immunol 2011 11 519-531.
7. Brinkmann V, Reichard U, Goosmann C, et al. Neutrophil extracellular traps kill bacteria. Science 2004; 303:1532-1535.
8. Metzler K D, Goosmann C, Lubojemska A, et al. A myeloperoxidase-containing complex regulates neutrophil elastase release and actin dynamics during NETosis. Cell Rep 2014; 8:883-896. An important mechanistic study on the signal s leading to NET formation.
9. Palmer LJ, Cooper PR, Ling MR, et al. Hypochlorous acid regulates neutrophil extracellular trap release in humans. Clin Exp Immunol 2012; 167:261-268.
10. Tessarz P, Kouzarides T. Histone core modifications regulating nucleosome structure and dynamics. Nat Rev Mol Cell Biol 2014; 15:703-708.
11. Yipp BG, Petri B, Salina D, et al. Infection-induced NETosis is a dynamic process involving neutrophil multitasking in vivo. Nat Med 2012; 18:1386-1393.
12. Yipp BG, Kubes P. NETosis: how vital is it? Blood 2013; 122:2784-2794.
13. Yousefi S, Mihalache C, Kozlowski E, et al. Viable neutrophils release mitochondrial DNA to form neutrophil extracellular traps. Cell Death Differ 2009; 16:1438-1444.
14. Courtney PA, Crockard AD, Williamson K, et al. Increased apoptotic peripheral blood neutrophils in systemic lupus erythematosus: relations with disease activity, antibodies to double stranded DNA, and neutropenia. Ann Rheum Dis 1999; 58:309-314.
15. Bouts YM, Wolthuis DF, Dirkx MF, et al. Apoptosis and NET formation in the pathogenesis of SLE. Autoimmunity 2012; 45:597-601.
16. Brandt L, Hedberg H. Impaired phagocytosis by peripheral blood granulocytes in systemic lupus erythematosus. Scand J Haematol 1969; 6:348-353.
17. Cairns AP, Crockard AD, McConnell JR, et al. Reduced expression of CD44 on monocytes and neutrophils in systemic lupus erythematosus: relations with apoptotic neutrophils and disease activity. Ann RheumDis2001; 60:950-955.
18. Donnelly S, Roake W, Brown S, et al. Impaired recognition of apoptotic neutrophils by the C1q/calreticulin and CD91 pathway in systemic lupus erythematosus. Arthritis Rheum 2006; 54:1543-1556.
19. Pieterse E, van der Vlag J. Breaking immunological tolerance in systemic lupus erythematosus. Front Immunol 2014; 5:164.
20. Alves CM, Marzocchi-Machado CM, Louzada-Junior P, et al. Superoxide anion production by neutrophils is associated with prevalent clinical manifestations in systemic lupus erythematosus. Clin Rheumatol 2008; 27:701-708.
21. Kaplan MJ. Neutrophils in the pathogenesis and manifestations of SLE. Nat Rev Rheumatol 2011; 7:691-699.
22. Hacbarth E, Kajdacsy-Balla A. Low density neutrophils in patients with systemic lupus erythematosus, rheumatoid art hritis, and acute rheumatic fever. Arthritis Rheum 1986; 29:1334-1342.
23. Villanueva E, Yalavarthi S, Berthier CC, et al. Netting neutrophils induce endothelial damage, infiltrate tissues, and e xpose immunostimulatory molecules in systemic lupus erythematosus. J Immunol 2011; 187:538-552.
24. Denny MF, Yalavarthi S, Zhao W, et al. A distinct subset of proinflammatory neutrophils isolat ed from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I IFNs. J Immunol 2010; 184:3284-3297.
25. Lande R, Ganguly D, Facchinetti V, et al. Neutrophils a ctivate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci Transl Med 2011; 3:73ra19.
26. Garcia-Romo GS, Caielli S, Vega B, et al. Netting neut rophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci Transl Med 2011; 3:73ra20.
27. Leffler J, Martin M, Gullstrand B, et al. Neutrophil extracellular tr aps that are not degraded in systemic lupus erythematosus activate complement exacerbating the disease. J Immunol 2012; 188:3522-3531.
28. Gehrke N, Mertens C, Zillinger T, et al. Oxidative dama ge of DNA confers resistance to cytosolic nuclease TREX1 degradation and potentiates STINGdependent immune sensing. Immunity 2013; 39:482-495.
29. Hakkim A,Furnrohr BG,Amann K,et al. Impairme nt of neutrophil extracellular trap degradation is associated with lupus nephritis Proc Natl Acad Sci U S A 2010, 107, 9813-9818.
30. Kahlenberg JM, Carmona-Rivera C, Smith CK, Kaplan MJ. Neutro phil extracellular trap-Associated protein activation of the NLRP3 inflammasome is enhanced in lupus macrophages. J Immunol 2013; 190:1217-1226.
31. Zhang S, Lu X, Shu X, et al. Elevated plasma cfDNA may be associated with active lupus nephritis and partially attributed to abnormal regulation of neutrophil extracellular traps (NETs) in patients with systemic lupus erythematosus. Intern Med 2014; 53:2763-2771.
32. van Bavel CC, Dieker J, Muller S, et al. Apoptosis-Associated acetylation on histone H2B is an epitope for lupus autoantibodies. Mol Immunol 2009; 47:511-516.
33. Neeli I, Khan SN, Radic M. Histone deimination as a response to inflammatory stimuli in neutrophils. J Immunol 2008; 180:1895-1902.
34. Pieterse E, Hofstra J, Berden J, et al. Acetylated histone s contribute to the immunostimulatory potential of neutrophil extracellular traps in systemic lupus erythematosus. Clin Exp Immunol 2015; 179:68-74.
35. Dwivedi N, Radic M. Citrullination of autoantigens implicates NETosis in the induction of autoimmunity. Ann Rheum Dis 2014; 73:483-491.
36. Dwivedi N, Neeli I, Schall N, et al. Deimination of linker histones links neutrophil extracellular trap release with autoantibodies in systemic autoimmunity. FASEB J 2014; 28:2840-2851.
37. Li P, Li M, Lindberg MR, et al. PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. J Exp Med 2010; 207:1853-1862.
38. Cheng F J, Zhou XJ, Zhao YF, et al. Human neutrophil peptide 1-3, a component of the neutrophil extracellular trap, as a potential biomarker of lupus nephritis. Int J Rheum Dis 2014. [Epub ahead of print]
39. SmithCK,Vivekanandan-GiriA, TangC, et al. Neutrophil extracellular trap-derived enzymes oxidize high-density lipoprotein: an additional proatherogenic mechanism in systemic lupus erythematosus. Arthritis Rheumatol 2014; 66:2 5 32-2544. This study establishes a link between NET formation and oxidation of high-density lipoprotein mediated by enzymes externalized in the traps. This adds an additional link between NETosis and vascular damage. The study also finds that antimalarials inhibit NET formation.
40. Wang W, Jian Z, Guo J, Ning X. Increased levels of serum myeloperoxidase in patients with active rheumatoid arthritis. Life Sci 2014; 117:19-23.
41. Brunner HI, Bennett MR, Mina R, et al. Association of noninvasively measured renal protein biomarkers with histologic features of lupus nephritis. Arthritis Rheum 2012; 64:2687-2697.
42. To rres-Salido MT, Cortes-Hernandez J, Vidal X, et al. Neutrophil gelatinaseassociated lipocalin as a biomarker for lupus nephritis. Nephrol Dial Transplant 2014; 29:1740-1749.
43. Elewa E, El Tokhy M, Fathy S, Talaat A. Predictive role of urinary neutrophil gelatinase-Associated lipocalin in lupus nephritis. Lupus 2015; 24:138-146.
44. Li Y, Hu F, Dai Y, et al. Serum antilipocalin 2 IgG is a novel biomarker in the diagnosis of systemic lupus erythematosus. Lupus 2014; 23:868-875.
45. Watson L, Tullus K, Pilkington C, et al. Urine biomarkers for monitoring juvenile lupus nephritis: a prospective longitudinal study. Pediatr Nephrol 2014; 29:397-405.
46. Brunner HI, Klein-Gitelman MS, Zelko F, et al. Blood-based candidate biomarkers of the presence of neuropsychiatric systemic lupus erythematosus in children. Lupus Sci Med 2014; 1:e000038.
47. Coit P,Yalavarthi S,Ognenovski M,et al. Epigenome profiling reveals significant DNA demethylation of interferon signature genes in lupus neutrophils J Autoimmun 2015 58 59-66. This manuscript reports the methylome profiling of lupus neutrophils and an association with demethylation of interferon-regulated genes.
48. Nakkuntod J, Avihingsanon Y,Mutirangura A, Hirankarn N. Hypomethylation of LINE-1 but not Alu in lymphocyte subsets o f systemic lupus erythematosus patients. Clin Chim Acta 2011; 412:1457-1461.
49. Sukapan P, Promnarate P, Avihingsanon Y, et al. Types of DNA methylation status of the interspersed repetitive se quences for LINE-1, Alu, HERV-E and HERV-K in the neutrophils from systemic lupus erythematosus patients and healthy controls. J Hum Genet 2014; 59:178-188.
50. Singh N, Traisak P, Martin KA, et al. Genomic alterations in abnormal neutrophils isolated from adult patients with systemic lupus erythematosus. Arthritis Res Ther 2014; 16:R165. This study reports specific genomic alterations in lupus LDGs when compared with normal-density lupus neutrophils.
51. Sang A, Zheng YY, Morel L. Contributions of B cells to lupus pathogenesis. Mol Immunol 2014; 62:329-338.
52. Zhuang H, Han S, Xu Y, et al. Toll-like receptor 7-stimulated tumor necrosis factor alpha causes bone marrow damage in systemic lupus erythematosus. Arthritis Rheumatol 2014; 66:140-151. This study establishes a link between TLR-7 mediated TNF synthesis and bone marrow damage in lupus.
53. Han JH, Umiker BR, Kazimirova AA, et al. Expression of an anti-RNA autoantibody in a mouse model of SLE increases neutrophil and monocyte numbers as well as IFN-I expression. Eur J Im munol 2014; 44:215-226.
54. Umiker BR,Andersson S,Fernandez L,et al. Dosage of X-linked Toll-like receptor 8 determines gender differences in the development of systemic lupus erythematosus Eur J Immunol 2014 44 1503-1516.
55. Lindau D, Mussard J, Rabsteyn A, et al. TLR9 independent interferon alpha production by neutrophils on NETosis in response to circulating chromatin, a key lupus autoan tigen. Ann Rheum Dis 2014; 73:2199-2207. Neutrophils exposed to chromatin become potent IFN-A producers in a TLR-9 independent manner.
56. Palanichamy A, Bauer JW, Yalavarthi S, et al. Neutrophil-medi ated IFN activation in the bone marrow alters B cell development in human and murine systemic lupus erythematosus. J Immunol 2014; 192:906-918. Neutrophils represent the main source of type I IFNs in the lupus bone marrow and drive B-cell abnormalities.
57. Coquery CM, Wade NS, Loo WM, et al. Neutrophils contribute to excess serum BAFF levels and promote CD4+ T cell and B cell responses in lupusprone mice. PLoS One 2014; 9:e1 02284. Lupus neutrophils are an important source of BAFF and induce abnormalities in adaptive immunity.
58. Khandpur R, Carmona-Rivera C, Vivekanandan-Giri A, et al. NETs are a source of citrullinated autoantigens an d stimulate inflammatory responses in rheumatoid arthritis. Sci Transl Med 2013; 5:178ra140.
59. Fuchs TA, Abed U, Goosmann C, et al. Novel cell death program leads to neutrophil extracellular traps. J Cell Biol 2007; 176:231-241.
60. Wang Y, Li M, Stadler S, et al. Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation. J Cell Biol 2009; 184:205-213.
61. Knight JS, Subramanian V, O'Dell AA, et al. Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lpr mice. Ann Rheum Dis 2014. [Epub ahead of print] Chemical inhibition of PAD, to block NET formation, abrogates many aspects of lupus disease and associated vascular damage in a mouse model.
62. Knight JS, Zhao W, Luo W, et al. Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupus. J Clin Invest 2013; 123:2981-2993.
63. Knight JS, Luo W, O'Dell AA, et al. Peptidylarginine deiminase inhibition reduces vascular damage and modulates innate immune responses in murine models of atherosclerosis. Circ Res 2014; 114:947-956. This study identified a putative role for PAD inhibition in the abrogation of atheroscleorotic plaque formation through modualtio n of NET/type I IFN pathways.
64. Lee SJ, Silverman E, Bargman JM. The role of antimalarial agents in the treatment of SLE and lupus nephritis. Nat Rev Nephrol 2011; 7: 718-729.
65. . Gupta AK, Giaglis S, Hasler P, Hahn S. Efficient neutrophil extracellular trap induction requires mobilization of both intracellular and extracellular calcium pools and is modulated by cyclosporine A. PLoS One 2014; 9 :e97088.
66. Mak A, Kow NY. Imbalance between endothelial damage and repair: a gateway to cardiovascular disease in systemic lupus erythematosus. Biomed Res Int 2014; 2014:178721.
67. Lorenz G, Desai J, Anders HJ. Lupus nephritis: update on mechanisms of systemic autoimmunity and kidney immunopathology. Curr Opin Nephrol Hypertens 2014; 23:211-217.
68. Colonna L, L ood C, Elkon KB. Beyond apoptosis in lupus. Curr Opin Rheumatol 2014; 26:459-466.
69. Carmona-Rivera C,Zhao W,Yalavarthi S,Kaplan MJ Neutrophil extracellular traps induce endothelial dysfuncti on in systemic lupus erythematosus through the activation of matrix metalloproteinase-2. Ann Rheum Dis 2014. [ Epub ahead of print] MMP-9 externalized in NETs induces a cell death programme in endothelial cells through activation of MMP-2. This phenom enon is enhanced in SLE.
70. McMahon M, Skaggs BJ, Grossman JM, et al. A panel of biomarkers is associated with increased risk of the presence and progression of atherosclerosis in women with systemic lupus erythematosus. Arthritis Rheumatol 2014; 66:130-139.